Paper35708136
Diagnosis of immune thrombocytopenia, including secondary forms, and selection of second-line treatment.
Bussel JB and 1 other. Haematologica, 2022. Cited by 15 papers, by iCite.
Cite this record
ConductScience Library. Diagnosis of immune thrombocytopenia, including secondary forms, and selection of second-line treatment. Papers, record 35708136. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/35708136
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Diagnosis of immune thrombocytopenia, including secondary forms, and selection of second-line treatment.
- PubMed
Topics11
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Agammaglobulinemia | Major topic |
| COVID-19 | Major topic |
| Purpura, Thrombocytopenic, Idiopathic | Major topic |
| Thrombocytopenia | Major topic |
| Adult | |
| COVID-19 Testing | |
| Female | |
| Humans | |
| Male | |
| Pregnancy | |
| Splenectomy |
Source PubMed
References86
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 34469646 | Mycophenolate Mofetil for First-Line Treatment of Immune Thrombocytopenia. | N Engl J Med | 2021 | https://conductscience.org/library/papers/34469646 | PubMed |
| 2 | 9221273 | 11 Beta-hydroxylase deficiency. | J Endocrinol Invest | 1995 | https://conductscience.org/library/papers/9221273 | PubMed |
| 3 | 27131591 | Omission of fetal sampling in treatment of subsequent pregnancies in fetal-neonatal alloimmune thrombocytopenia. | Am J Obstet Gynecol | 2016 | https://conductscience.org/library/papers/27131591 | PubMed |
| 4 | 30520045 | Platelet transfusion practices in immune thrombocytopenia related hospitalizations. | Transfusion | 2019 | https://conductscience.org/library/papers/30520045 | PubMed |
| 5 | 32374026 | Practical guidance for the management of adults with immune thrombocytopenia during the COVID-19 pandemic. | Br J Haematol | 2020 | https://conductscience.org/library/papers/32374026 | PubMed |
| 6 | 31770441 | Updated international consensus report on the investigation and management of primary immune thrombocytopenia. | Blood Adv | 2019 | https://conductscience.org/library/papers/31770441 | PubMed |
| 7 | 34467402 | Fostamatinib for the Treatment of Hospitalized Adults With Coronavirus Disease 2019: A Randomized Trial. | Clin Infect Dis | 2022 | https://conductscience.org/library/papers/34467402 | PubMed |
| 8 | 26693428 | Prevalence of thyroid dysfunction among young females in a South Indian population. | Indian J Endocrinol Metab | 2015 | https://conductscience.org/library/papers/26693428 | PubMed |
| 9 | 17698634 | Multiagent induction and maintenance therapy for patients with refractory immune thrombocytopenic purpura (ITP). | Blood | 2007 | https://conductscience.org/library/papers/17698634 | PubMed |
| 10 | 33206002 | Depot Medroxyprogesterone Acetate Use and Blood Lead Levels in a Cohort of Young Women. | Environ Health Perspect | 2020 | https://conductscience.org/library/papers/33206002 | PubMed |
| 11 | 28630121 | A novel recombinant human thrombopoietin therapy for the management of immune thrombocytopenia in pregnancy. | Blood | 2017 | https://conductscience.org/library/papers/28630121 | PubMed |
| 12 | 19731307 | Repeated courses of rituximab in chronic ITP: Three different regimens. | Am J Hematol | 2009 | https://conductscience.org/library/papers/19731307 | PubMed |
| 13 | 33317862 | Inherited thrombocytopenias: an updated guide for clinicians. | Blood Rev | 2021 | https://conductscience.org/library/papers/33317862 | PubMed |
| 14 | 28759125 | Thrombopoietin receptor agonist switch in adult primary immune thrombocytopenia patients: A retrospective collaborative survey involving 4 Spanish centres. | Eur J Haematol | 2017 | https://conductscience.org/library/papers/28759125 | PubMed |
| 15 | 35201417 | Refractory primary immune thrombocytopenia (ITP): current clinical challenges and therapeutic perspectives. | Ann Hematol | 2022 | https://conductscience.org/library/papers/35201417 | PubMed |
| 16 | 33855698 | Immune thrombocytopenia during the COVID-19 pandemic. | Br J Haematol | 2021 | https://conductscience.org/library/papers/33855698 | PubMed |
| 17 | 10847256 | The bleeding risk and natural history of idiopathic thrombocytopenic purpura in patients with persistent low platelet counts. | Arch Intern Med | 2000 | https://conductscience.org/library/papers/10847256 | PubMed |
| 18 | 21098742 | Pregnancy outcomes after maternal exposure to rituximab. | Blood | 2011 | https://conductscience.org/library/papers/21098742 | PubMed |
| 19 | 32195065 | Post-splenectomy Sepsis: A Review of the Literature. | Cureus | 2020 | https://conductscience.org/library/papers/32195065 | PubMed |
| 20 | 35283346 | Pre- and postpregnancy platelet counts: evaluating accuracy of gestational thrombocytopenia and immune thrombocytopenia purpura diagnoses. | Am J Obstet Gynecol MFM | 2022 | https://conductscience.org/library/papers/35283346 | PubMed |
Cited by8
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 15 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42928941 | MicroRNA cargo of extracellular vesicles as mediators of immune dysregulation in pediatric immune thrombocytopenia: from pathogenetic drivers to biomarkers. | Front Genet | 2026 | https://conductscience.org/library/papers/42928941 | PubMed |
| 41900980 | Thrombocytopenia in Pregnancy: Clinical Challenges, Maternal-Fetal Risks, and Management Strategies. | Life (Basel) | 2026 | https://conductscience.org/library/papers/41900980 | PubMed |
| 41890569 | ITP, easy as EBV: a rare case of severe immune thrombocytopenic purpura secondary to Epstein-Barr virus. | Blood Sci | 2026 | https://conductscience.org/library/papers/41890569 | PubMed |
| 40746333 | Use and Effects of Eltrombopag in Pregnant Woman With Difficult-to-Treat Idiopathic Thrombocytopenic Purpura (ITP). | Case Rep Hematol | 2025 | https://conductscience.org/library/papers/40746333 | PubMed |
| 40052221 | YC-4-3, a Novel Glycogen Synthase Kinase 3β Inhibitor, Alleviates the Endoplasmic Reticulum Stress of Macrophages in Primary Immune Thrombocytopenia. | Adv Sci (Weinh) | 2025 | https://conductscience.org/library/papers/40052221 | PubMed |
| 39597882 | The Many Faces of Immune Thrombocytopenia: Mechanisms, Therapies, and Clinical Challenges in Oncological Patients. | J Clin Med | 2024 | https://conductscience.org/library/papers/39597882 | PubMed |
| 37371143 | Predictor Factors for Chronicity in Immune Thrombocytopenic Purpura in Children. | Children (Basel) | 2023 | https://conductscience.org/library/papers/37371143 | PubMed |
| 36168521 | First-line Therapy for Immune Thrombocytopenia: Time for Change. | Hemasphere | 2022 | https://conductscience.org/library/papers/36168521 | PubMed |
Genes13
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/35708136
GET https://conductscience.org/api/papers/v1/35708136/references?page=2